An exciting recent study published in Journal of Clinical Medicine by Macech et al. shows that using HMP with LifePort Kidney Transporter after a period of SCS can safely prolong kidney preservation time without compromising transplant outcomes.
Some important findings:
- Kidneys preserved with SCS + HMP had significantly lower rates of DGF compared to SCS alone – 28.3% vs 44.8%!
- Despite longer total CIT, graft and patient survival at 2 years remained comparable between the two groups
- No harmful threshold for HMP duration was identified
The key takeaway:
When using LifePort Kidney Transporter, HMP following a period of SCS safely extends preservation time for transplant teams and is associated with a lower incidence of DGF, allowing more time for optimization, logistics, and recipient allocation
Read the full article here.
